Annual EBIT
$730.70 M
+$321.30 M+78.48%
31 December 2023
Summary:
DexCom annual earnings before interest & taxes is currently $730.70 million, with the most recent change of +$321.30 million (+78.48%) on 31 December 2023. During the last 3 years, it has risen by +$421.00 million (+135.94%). DXCM annual EBIT is now at all-time high.DXCM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$182.10 M
-$10.50 M-5.45%
30 September 2024
Summary:
DexCom quarterly earnings before interest & taxes is currently $182.10 million, with the most recent change of -$10.50 million (-5.45%) on 30 September 2024. Over the past year, it has dropped by -$63.20 million (-25.76%). DXCM quarterly EBIT is now -27.48% below its all-time high of $251.10 million, reached on 31 December 2023.DXCM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$762.90 M
-$63.20 M-7.65%
30 September 2024
Summary:
DexCom TTM earnings before interest & taxes is currently $762.90 million, with the most recent change of -$63.20 million (-7.65%) on 30 September 2024. Over the past year, it has increased by +$145.40 million (+23.55%). DXCM TTM EBIT is now -7.65% below its all-time high of $826.10 million, reached on 30 June 2024.DXCM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +78.5% | -25.8% | +23.6% |
| 3 y3 years | +135.9% | +53.9% | +105.0% |
| 5 y5 years | +804.0% | +199.0% | +770.4% |
DXCM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +165.1% | -27.5% | +1651.0% | -7.7% | +204.9% |
| 5 y | 5 years | at high | +804.0% | -27.5% | +1651.0% | -7.7% | +770.4% |
| alltime | all time | at high | +804.0% | -27.5% | +207.9% | -7.7% | +710.3% |
DexCom EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $182.10 M(-5.5%) | $762.90 M(-7.7%) |
| June 2024 | - | $192.60 M(+40.5%) | $826.10 M(+3.4%) |
| Mar 2024 | - | $137.10 M(-45.4%) | $798.70 M(+9.3%) |
| Dec 2023 | $730.70 M(+78.5%) | $251.10 M(+2.4%) | $730.70 M(+18.3%) |
| Sept 2023 | - | $245.30 M(+48.5%) | $617.50 M(+18.1%) |
| June 2023 | - | $165.20 M(+139.1%) | $523.00 M(+19.5%) |
| Mar 2023 | - | $69.10 M(-49.9%) | $437.80 M(+6.7%) |
| Dec 2022 | $409.40 M(+48.5%) | $137.90 M(-8.6%) | $410.20 M(+45.1%) |
| Sept 2022 | - | $150.80 M(+88.5%) | $282.70 M(+13.0%) |
| June 2022 | - | $80.00 M(+92.8%) | $250.20 M(-8.0%) |
| Mar 2022 | - | $41.50 M(+299.0%) | $272.10 M(-1.6%) |
| Dec 2021 | $275.60 M(-11.0%) | $10.40 M(-91.2%) | $276.60 M(-25.7%) |
| Sept 2021 | - | $118.30 M(+16.1%) | $372.10 M(+5.3%) |
| June 2021 | - | $101.90 M(+121.5%) | $353.30 M(+11.1%) |
| Mar 2021 | - | $46.00 M(-56.6%) | $317.90 M(+2.6%) |
| Dec 2020 | $309.70 M(+88.3%) | $105.90 M(+6.4%) | $309.70 M(-1.2%) |
| Sept 2020 | - | $99.50 M(+49.6%) | $313.40 M(+14.0%) |
| June 2020 | - | $66.50 M(+75.9%) | $274.80 M(+28.4%) |
| Mar 2020 | - | $37.80 M(-65.5%) | $214.00 M(+30.1%) |
| Dec 2019 | $164.50 M(-258.5%) | $109.60 M(+80.0%) | $164.50 M(-244.6%) |
| Sept 2019 | - | $60.90 M(+968.4%) | -$113.80 M(-9.0%) |
| June 2019 | - | $5.70 M(-148.7%) | -$125.00 M(+29.8%) |
| Mar 2019 | - | -$11.70 M(-93.1%) | -$96.30 M(-7.2%) |
| Dec 2018 | -$103.80 M(+189.9%) | -$168.70 M(-439.4%) | -$103.80 M(-232.7%) |
| Sept 2018 | - | $49.70 M(+44.5%) | $78.20 M(+156.4%) |
| June 2018 | - | $34.40 M(-279.2%) | $30.50 M(-300.7%) |
| Mar 2018 | - | -$19.20 M(-244.4%) | -$15.20 M(-57.5%) |
| Dec 2017 | -$35.80 M(-44.2%) | $13.30 M(+565.0%) | -$35.80 M(-35.8%) |
| Sept 2017 | - | $2.00 M(-117.7%) | -$55.80 M(-26.8%) |
| June 2017 | - | -$11.30 M(-71.6%) | -$76.20 M(-10.2%) |
| Mar 2017 | - | -$39.80 M(+494.0%) | -$84.90 M(+32.2%) |
| Dec 2016 | -$64.20 M(+12.4%) | -$6.70 M(-63.6%) | -$64.20 M(+14.8%) |
| Sept 2016 | - | -$18.40 M(-8.0%) | -$55.90 M(-30.0%) |
| June 2016 | - | -$20.00 M(+4.7%) | -$79.90 M(+25.8%) |
| Mar 2016 | - | -$19.10 M(-1293.8%) | -$63.50 M(+11.2%) |
| Dec 2015 | -$57.10 M(+165.6%) | $1.60 M(-103.8%) | -$57.10 M(0.0%) |
| Sept 2015 | - | -$42.40 M(+1077.8%) | -$57.10 M(+189.8%) |
| June 2015 | - | -$3.60 M(-71.7%) | -$19.70 M(-10.0%) |
| Mar 2015 | - | -$12.70 M(-893.8%) | -$21.90 M(+1.9%) |
| Dec 2014 | -$21.50 M | $1.60 M(-132.0%) | -$21.50 M(-15.4%) |
| Sept 2014 | - | -$5.00 M(-13.8%) | -$25.40 M(-3.1%) |
| June 2014 | - | -$5.80 M(-52.8%) | -$26.20 M(-13.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$12.30 M(+434.8%) | -$30.30 M(+4.8%) |
| Dec 2013 | -$28.90 M(-48.0%) | -$2.30 M(-60.3%) | -$28.90 M(-17.2%) |
| Sept 2013 | - | -$5.80 M(-41.4%) | -$34.90 M(-24.8%) |
| June 2013 | - | -$9.90 M(-9.2%) | -$46.40 M(-9.4%) |
| Mar 2013 | - | -$10.90 M(+31.3%) | -$51.20 M(-8.1%) |
| Dec 2012 | -$55.60 M(+24.4%) | -$8.30 M(-52.0%) | -$55.70 M(-6.6%) |
| Sept 2012 | - | -$17.30 M(+17.7%) | -$59.62 M(+7.2%) |
| June 2012 | - | -$14.70 M(-4.5%) | -$55.59 M(+15.2%) |
| Mar 2012 | - | -$15.40 M(+26.1%) | -$48.26 M(+8.0%) |
| Dec 2011 | -$44.70 M(-16.8%) | -$12.21 M(-8.0%) | -$44.70 M(+5.5%) |
| Sept 2011 | - | -$13.28 M(+80.3%) | -$42.37 M(-0.2%) |
| June 2011 | - | -$7.36 M(-37.8%) | -$42.44 M(-8.9%) |
| Mar 2011 | - | -$11.84 M(+19.9%) | -$46.57 M(-13.3%) |
| Dec 2010 | -$53.70 M(+18.1%) | -$9.88 M(-26.0%) | -$53.70 M(+0.8%) |
| Sept 2010 | - | -$13.35 M(+16.2%) | -$53.25 M(+3.6%) |
| June 2010 | - | -$11.49 M(-39.4%) | -$51.38 M(-3.5%) |
| Mar 2010 | - | -$18.97 M(+101.2%) | -$53.24 M(+17.1%) |
| Dec 2009 | -$45.48 M(-13.9%) | -$9.43 M(-17.9%) | -$45.48 M(-6.8%) |
| Sept 2009 | - | -$11.49 M(-13.9%) | -$48.79 M(-4.9%) |
| June 2009 | - | -$13.35 M(+19.0%) | -$51.29 M(-0.2%) |
| Mar 2009 | - | -$11.21 M(-12.0%) | -$51.40 M(-2.7%) |
| Dec 2008 | -$52.83 M(+13.2%) | -$12.74 M(-8.9%) | -$52.83 M(+1.1%) |
| Sept 2008 | - | -$13.99 M(+4.0%) | -$52.27 M(+5.0%) |
| June 2008 | - | -$13.46 M(+6.4%) | -$49.78 M(+4.0%) |
| Mar 2008 | - | -$12.64 M(+3.8%) | -$47.86 M(+2.5%) |
| Dec 2007 | -$46.68 M(-5.4%) | -$12.18 M(+5.9%) | -$46.68 M(+0.9%) |
| Sept 2007 | - | -$11.50 M(-0.3%) | -$46.26 M(-5.6%) |
| June 2007 | - | -$11.54 M(+0.7%) | -$49.01 M(-0.7%) |
| Mar 2007 | - | -$11.46 M(-2.6%) | -$49.38 M(+0.1%) |
| Dec 2006 | -$49.32 M(+52.1%) | -$11.76 M(-17.5%) | -$49.32 M(-1.7%) |
| Sept 2006 | - | -$14.26 M(+19.7%) | -$50.17 M(+17.3%) |
| June 2006 | - | -$11.90 M(+4.4%) | -$42.77 M(+13.4%) |
| Mar 2006 | - | -$11.40 M(-9.5%) | -$37.71 M(+16.3%) |
| Dec 2005 | -$32.43 M(+130.5%) | -$12.60 M(+83.7%) | -$32.43 M(+63.6%) |
| Sept 2005 | - | -$6.86 M(+0.3%) | -$19.82 M(+52.9%) |
| June 2005 | - | -$6.84 M(+11.8%) | -$12.96 M(+111.8%) |
| Mar 2005 | - | -$6.12 M | -$6.12 M |
| Dec 2004 | -$14.07 M(+38.1%) | - | - |
| Dec 2003 | -$10.18 M(+61.4%) | - | - |
| Dec 2002 | -$6.31 M(-6.1%) | - | - |
| Dec 2001 | -$6.72 M(+67.5%) | - | - |
| Dec 2000 | -$4.01 M | - | - |
FAQ
- What is DexCom annual earnings before interest & taxes?
- What is the all time high annual EBIT for DexCom?
- What is DexCom annual EBIT year-on-year change?
- What is DexCom quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for DexCom?
- What is DexCom quarterly EBIT year-on-year change?
- What is DexCom TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for DexCom?
- What is DexCom TTM EBIT year-on-year change?
What is DexCom annual earnings before interest & taxes?
The current annual EBIT of DXCM is $730.70 M
What is the all time high annual EBIT for DexCom?
DexCom all-time high annual earnings before interest & taxes is $916.70 M
What is DexCom annual EBIT year-on-year change?
Over the past year, DXCM annual earnings before interest & taxes has changed by +$321.30 M (+78.48%)
What is DexCom quarterly earnings before interest & taxes?
The current quarterly EBIT of DXCM is $182.10 M
What is the all time high quarterly EBIT for DexCom?
DexCom all-time high quarterly earnings before interest & taxes is $251.10 M
What is DexCom quarterly EBIT year-on-year change?
Over the past year, DXCM quarterly earnings before interest & taxes has changed by -$63.20 M (-25.76%)
What is DexCom TTM earnings before interest & taxes?
The current TTM EBIT of DXCM is $762.90 M
What is the all time high TTM EBIT for DexCom?
DexCom all-time high TTM earnings before interest & taxes is $826.10 M
What is DexCom TTM EBIT year-on-year change?
Over the past year, DXCM TTM earnings before interest & taxes has changed by +$145.40 M (+23.55%)